MedTrace Logo

Implementing Precision Medicine in cOmmunity HospiTALs

NCT05283044 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 10000

Last updated 2025-06-25

No results posted yet for this study

Summary

This is a prospective biomarker study that aims at demonstrating the impact of liquid biopsy to deliver better treatment for cancer patients with metastatic disease managed in the community setting

Conditions

Interventions

BIOLOGICAL

biopsy liquid

Patient performs a blood test at treatment baseline

Sponsors & Collaborators

  • Gustave Roussy, Cancer Campus, Grand Paris

    lead OTHER

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-06-29
Primary Completion
2028-11-15
Completion
2030-04-15

Countries

  • France
  • French Polynesia
  • New Caledonia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05283044 on ClinicalTrials.gov